With you. Along the way! 609.529.9282, email us: kyle.abuarjah@biopulseconsulting.com
How we Work at a glance
Personalized Communication
Personalized service customized to your drug development needs. Time is of the essence, and therefore BioPulse will help you by effectivly connecting you with one of our prequalified CROs and CDMOs within our vast network.
Guidance
With our years of experience, BioPulsers can assist you with your scientific and regulatory needs utilizing the latest industry guidance.
Proposal Generation
We guarantee competitive and comprehensive proposals from our prequalified network of CROs and CDMOs.
Mutual Feedback
Everyone deserves honest feedback. BioPulse will ensure that mutual feedback will be provided after project completion.
BioPulsers
Founder & CEO
Kyle Abuarjah has over 20 years of experience in the CRO industry in the Large Molecule arena. Kyle started BioPulse Consulting to serve an unmet need and provide a cost effective outsourcing model for both CROs/CDMOs and Biopharmaceutical companies. Prior to BioPulse, Kyle provided Business Development leadership for Primera Analytical Solutions, Alliance Pharma, CMIC, Charles River Laboratories, SGS Life Sciences, and Quest Diagnostics. In addition, Kyle provided leadership in building the Large Molecule Bioanalytical lab operation at CMIC (formerly JCL Bioassay USA). Kyle began his career on the bench as a Medical Laboratory Technologist in diagnostics. Then, joined the CRO industry and worked in different roles in Immunoassay bioanalysis including Project Management, Business Development, and as a Principal Investigator. Kyle received his BSc in Clinical Laboratory Sciences from the University of Texas Medical Branch at Galveston and received his Masters of Business Administration (MBA) from Athabasca University. Kyle is certified by the American Society of Clinical Pathology (ASCP) and a member of the American Association of Pharmaceutical Scientists (AAPS). In his free time, when there is a free time, Kyle spends his time with Prada (Ms. Parudi) the kitty office manager.
Business Strategy Consultant
John LaHaye has over 30 years of experience with public and PE/VC portfolio companies in Life Sciences, Biopharma and High-Tech Enterprise industries. Executive with proven track record in delivering global strategic and financial growth outcomes. Over the years, his career focused on: Mergers and Acquisitions, Product Management, Sales & Marketing, Global Strategic Account Management, Operations Management, Software Engineering, Manufacturing, Supply Chain Logistics and Operations Research. Advisory Board Member.
Experience in: structuring, negotiating and executing complex solution-oriented commercial transactions; instituting customer excellence programs; building and leading high-performing teams; resource optimization; product positioning, market segmentation, go-to-market plans; designing sales incentive compensation plans for business development and account management functions; establishing standard work practices for the management of the sales funnel aligned with the sales process and cross-functional teams; improving contract management process; defining customer value proposition and implementing value-based pricing; and, forming strategic partnership agreements. John's will be responsible for the strategic expansion and partnerships at BioPulse.
John graduated from Montreal University Polytechnic Institute with a B. Sc. in Engineering, Operations Research & International Business.
Business Development Consultant
Sara Khalaf has over 10 years of clinical experience in Health IT providing product implementation, project management, customer support, and change management. Prior to BioPulse, Sara provided implementation and change management leadership for Cerner-Oracle, PwC, and M&S Informatics. Sara’s diverse background, interpersonal and communication skills coupled with her enthusiasm, drive, and customer centricity will be instrumental in providing our clients and partners with the ultimate experience. Sara will be responsible for expanding our customer reach and streamlining internal processes at BioPulse. Sara received her BA in Psychology and Masters of Art in Cognitive Science from the University of Colorado Boulder.
scientific Advisory board
Scientific Advisor-Clinical Pharmacology
Dr. Suliman Al-Fayoumi is currently a senior Consultant with Nuventra supporting several small Biotech companies primarily based in USA. Prior to taking-up consulting in 2017 then joining Allucent in 2021, Dr. Al-Fayoumi served as Vice President of Translational Sciences and Clinical Pharmacology at Cell Therapeutics Biopharma Inc., a niche hematology-oncology company based in Seattle, WA between 2013-2017. Prior to joining CTI Biopharma, Dr. Al-Fayoumi served as Director of Preclinical and Clinical Pharmacology and Interim Head of Research at Acucela Inc., a niche Ophthalmology company based in Seattle, WA between 2010-2013. Prior to joining Acucela, Dr. Al-Fayoumi served as Associate Director of Global PK/PD within the DMPK Department at Novartis Pharmaceuticals (East Hanover, NJ), where he supported the Cardiovascular & Metabolism (CVM) Franchise between 2006-2010. Prior to Joining Novartis Pharmaceuticals, Dr. Al-Fayoumi served as Senior Clinical Pharmacology Reviewer at US FDA between 1999-2006 supporting GI, anticoagulants, anesthetics, addiction and dermatology Drug Product Divisions. While at FDA, Dr. Al-Fayoumi was the primary clinical pharmacology reviewer for several high profile drug applications such as Nexium, Prilosec OTC, Prevacid, Oxycontin, Ximelagatran, Asacol, Remicade, Lovenox, Innohep, Exjade, Propulsid, Etreva, Fabrazyme, Zegerid, Protonix, Lotronex and Zelnorm. Dr. Al-Fayoumi received several awards for outstanding support of and significant contributions to the achievement of excellence in FDA drug safety initiatives related to optimal dosing and lowest effective dose including CDER’s Frances O. Kelsey Drug Safety Excellence Award. Dr. Al-Fayoumi has a B.S. degree in Pharmacy from Jordan University of Science and Technology. Dr. Al-Fayoumi received a Ph.D. in Pharmacokinetics from the University of Florida (Gainesville, FL) in 1998, and MBA degree in International Business from Fairleigh Dickinson University (Madison, NJ) in 2009. Dr. Al-Fayoumi is a member of the American Diabetes Association (ADA), the American College of Clinical Pharmacology (ACCP), the American Society of Clinical Pharmacology and Therapeutics (ASCPT), the American Association of Pharmaceutical Sciences (AAPS), European Hematology Association (EHA), and The American Society of Clinical Oncology (ASCO).
Scientific Advisor-Bioanalysis
Dr. Philip Oldfield started his scientific career in 1974 in the Clinical Biochemistry Department at the Royal Postgraduate Medical School, Hammersmith Hospital London, England. Since then he has obtained three degrees; including a D.Phil obtained in 1982. The subject of his research thesis was “Proteolytic Control and Rheumatoid Disease”. In 1986 he was given the Baker Award for his work on Digoxin-Like-Immunoreactive-Substances. Dr Oldfield has had over 25 years experience in service to the pharmaceutical and biopharmaceutical industry specializing in LBA techniques and Good Laboratory Practice. Dr Oldfield is an Associate Member of the Royal College of Pathologists, a Fellow of the Royal Society of Chemistry, and a Member of the American Association of Pharmaceutical Scientists (currently the Past Chair of the Ligand Binding Assay Bioanalytical Focus Group). In conjunction with BioPulse, Dr Oldfield operates Philip Oldfield Bioanalytical Consulting where he provides strategic bioanalytical consulting with a commitment to quality focusing on biological and oligonucleotide therapeutics. Prior to that, Dr Oldfield was Scientific Director at Charles River Laboratories where he managed the scientific and technical operation for the Immunoassay group. In addition, he likes to maintain a link with the local universities, and has been involved in supervising postgraduate students, as well the occasional lecture. He is currently involved as a committee member to organize symposia and workshops as part of the Drug Development Program Course at the University of McGill.
Site Content
Detail your services
If customers can’t find it, it doesn’t exist. Clearly list and describe the services you offer. Also, be sure to showcase a premium service.
Announce coming events
Having a big sale, on-site celebrity, or other event? Be sure to announce it so everybody knows and gets excited about it.
Display real testimonials
Are your customers raving about you on social media? Share their great stories to help turn potential customers into loyal ones.
Promote current deals
Running a holiday sale or weekly special? Definitely promote it here to get customers excited about getting a sweet deal.
Share the big news
Have you opened a new location, redesigned your shop, or added a new product or service? Don't keep it to yourself, let folks know.
Display their FAQs
Customers have questions, you have answers. Display the most frequently asked questions, so everybody benefits.